Company Summary - Advanced Medical Solutions Group PLC (LSE:AMS)
FTSE AIM All Share Health Care Equipment & ServicesMarket cap: £56.194m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Research, Development, Manufacture and Distribution of novel, high performance polymers for use as wound dressings
| Financials - Prelim (9/3/2010) | ||
|---|---|---|
| Turnover | £m | 24.09 |
| Pre-tax Profit | £m | 2.39 |
| EPS | p | 2.87 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| Dr. Geoffrey Vernon | Chairman |
| Dr. Don Evans | Chief Executive |
| Mary Tavener | Finance Director & Company Sec |
Products Brands & Subsidiaries
Products & Brands
Fenistil; Flexipore; Merfen; Mitraflex; Replicare; Savlon ActivHeal; Spyroflex; Trofolastin(R) Scar Reduction
Subsidiaries
Advanced Medical Solutions Ltd; Advanced Medical Solutions (UK) Ltd; MedLogic Global Holdings Ltd...
Broker Sentiment (4 brokers)
| Heading | Date |
|---|---|
| Offer Talks Terminated | 18/03/2010 |
| Rule 8.3- Advanced Medical Solutio... | 17/03/2010 |
| Rule 8.3- Advanced Medical Solutio... | 16/03/2010 |
